Filing Details
- Accession Number:
- 0001144204-19-000725
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-04 19:19:47
- Reporting Period:
- 2019-01-02
- Accepted Time:
- 2019-01-04 19:19:47
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 896264 | Usana Health Sciences Inc | USNA | Medicinal Chemicals & Botanical Products (2833) | 870500306 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1636301 | Ltd Global Gull | Po Box N-4899, 2/F Bahamas Financial Ctr Shirley &Amp; Charlotte Streets Nassau C5 BH1-1000 | No | No | Yes | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2019-01-02 | 7,131 | $116.25 | 9,918,483 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-02 | 2,600 | $117.00 | 9,915,883 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-02 | 200 | $117.68 | 9,915,683 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 7,096 | $113.07 | 9,908,587 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 2,316 | $113.86 | 9,906,271 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 700 | $115.25 | 9,905,571 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-03 | 100 | $115.97 | 9,905,471 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-04 | 1,700 | $113.17 | 9,903,771 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-04 | 3,223 | $114.23 | 9,900,548 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-04 | 4,474 | $115.00 | 9,896,074 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-04 | 160 | $116.11 | 9,895,914 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- Weighted average price. Price range in multiple transactions was $115.64 to $116.60, inclusive.
- The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- Weighted average price. Price range in multiple transactions was $116.64 to $117.61, inclusive.
- Weighted average price. Price range in multiple transactions was $117.65 to $117.70, inclusive.
- Weighted average price. Price range in multiple transactions was $112.53 to $113.51, inclusive.
- Weighted average price. Price range in multiple transactions was $113.57 to $114.46, inclusive.
- Weighted average price. Price range in multiple transactions was $114.67 to $115.56, inclusive.
- Weighted average price. Price range in multiple transactions was $112.67 to $113.66, inclusive.
- Weighted average price. Price range in multiple transactions was $113.71 to $114.69, inclusive.
- Weighted average price. Price range in multiple transactions was $114.71 to $115.67, inclusive.
- Weighted average price. Price range in multiple transactions was $116.10 to $116.13, inclusive.
Billionaire Hedge Funds
